Article

Circulating nucleic acids as liquid biopsies for disease prediction, screening and diagnosis

2023-10-24

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ee9275b9-4659-582b-a4a6-e26e64fc7d77
DOI: 10.1007/s11426-023-1727-9

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating nucleic acids as liquid biopsies for disease prediction, screening and diagnosisDOI 10.1007/s11426-023-1727-9Read

Liquid Biopsy in the Clinical Management of CancersSemantic proximity Read

A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment ResponseSemantic proximity Read

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)Semantic proximity Read

ctDNA as a Cancer Biomarker: A Broad OverviewSemantic proximity Read

Liquid Biopsy: Approaches to Dynamic Genotyping in CancerSemantic proximity Read

Liquid biopsies across the cancer care continuum.Semantic proximity Read

Liquid biopsy: current technology and clinical applicationsSemantic proximity Read

Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.Semantic proximity Read

ctDNA as a cancer biomarker: A broad overview.Semantic proximity Read

Challenges and Opportunities in Liquid Biopsy for Hematologic MalignanciesSemantic proximity Read

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?Semantic proximity Read

Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platformsSemantic proximity Read